Vitrolife’s vision is to fulfil the dream of having a baby. We support our customers to achieve successful treatment outcomes by providing valued solutions and services for assisted reproduction. Together. All the way.
Vitrolife is a global company contributing products within the IVF field. Our mission is to support customers to achieve successful treatment outcomes by providing valued solutions and services for assisted reproduction.
Founded in 1994 Vitrolife was one of the first companies providing IVF laboratories with high quality ready-to-use culture media. Today our portfolio holds products all the way from oocyte retrieval to transfer of the embryo.
Vitrolife has approximately 370 employees and the headquarter is located in Sweden with additional locations and production facilities in more than ten countries world-wide.
The Vitrolife share is listed on the NASDAQ Stockholm, Nordic Mid Cap.
Research and development
Today we collaborate with several researchers within the field of ART, both universities and clinics. A valuable asset in our research and development is our top of the line development laboratory where we make continuous improvements on the current product line and develop new products.
To us, quality is being passionate about all the details leading up to the most supportive products in the most protective environment for the most viable embryo.
High pregnancy rates depend on numerous factors, some of which are beyond human control. That is why we are devoted to control everything that can be controlled in order to achieve high pregnancy rates. This includes every dimension of quality regarding media, instruments and procedures when performing IVF. Consequently our QC tests span from each single LOT of raw material to microscopic inspection of every single micropipette.
Learn more about what quality means to us.
Our products are developed with the aim to improve pregnancy rates. Another focus for us is the safety for the patient and the embryologist or gynecologist.
The CE mark on our products means that they comply with the demands for safety that the European Union’s Medical Device Directive has on this type of products. We have worked for and will continue to insist on the question of the importance of CE marked products becoming a requirement in fertility treatment.
Most of our products have CE-mark, FDA-clearance, TGA-approval as well as approval from SFDA and Canada Health.
Read more about our commitment to quality.